ALBI Fundamental Analysis - GASCOGNE

Name: GASCOGNE (ALBI) Stock
Brand: GASCOGNE
Rating: 4 (3 reviews)

Fundamental Rating

ALBI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 14 industry peers in the Containers & Packaging industry. Both the profitability and financial health of ALBI have multiple concerns. ALBI has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALBI has reported negative net income.

In the past year ALBI had a positive cash flow from operations.

Of the past 5 years ALBI 4 years were profitable.

ALBI had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of ALBI (-0.10%) is worse than 69.23% of its industry peers.

ALBI has a worse Return On Equity (-0.29%) than 69.23% of its industry peers.

Looking at the Return On Invested Capital, with a value of 0.88%, ALBI is doing worse than 69.23% of the companies in the same industry.

ALBI had an Average Return On Invested Capital over the past 3 years of 4.10%. This is below the industry average of 6.73%.

		Industry Rank	Sector Rank
ROA	-0.1%
ROE	-0.29%
ROIC	0.88%

ROA(3y)2.18%

ROA(5y)2.37%

ROE(3y)5.63%

ROE(5y)6.16%

ROIC(3y)4.1%

ROIC(5y)4.24%

1.3 Margins

ALBI has a Operating Margin of 1.55%. This is in the lower half of the industry: ALBI underperforms 69.23% of its industry peers.

In the last couple of years the Operating Margin of ALBI has declined.

Looking at the Gross Margin, with a value of 25.55%, ALBI is doing worse than 69.23% of the companies in the same industry.

ALBI's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	1.55%
PM (TTM)	N/A
GM	25.55%

OM growth 3Y-27.15%

OM growth 5Y-15.85%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.32%

GM growth 5Y-1.26%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALBI is creating some value.

Compared to 1 year ago, ALBI has more shares outstanding

ALBI has more shares outstanding than it did 5 years ago.

ALBI has a worse debt/assets ratio than last year.

2.2 Solvency

ALBI has an Altman-Z score of 1.30. This is a bad value and indicates that ALBI is not financially healthy and even has some risk of bankruptcy.

ALBI's Altman-Z score of 1.30 is on the low side compared to the rest of the industry. ALBI is outperformed by 69.23% of its industry peers.

ALBI has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.

The Debt to Equity ratio of ALBI (1.19) is worse than 84.62% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.19
Debt/FCF	N/A
Altman-Z	1.3

ROIC/WACC0.25

WACC3.54%

2.3 Liquidity

ALBI has a Current Ratio of 1.79. This is a normal value and indicates that ALBI is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of ALBI (1.79) is better than 61.54% of its industry peers.

ALBI has a Quick Ratio of 1.07. This is a normal value and indicates that ALBI is financially healthy and should not expect problems in meeting its short term obligations.

ALBI has a Quick ratio of 1.07. This is in the better half of the industry: ALBI outperforms 76.92% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.79
Quick Ratio	1.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALBI have decreased strongly by -122.74% in the last year.

ALBI shows a decrease in Revenue. In the last year, the revenue decreased by -4.87%.

ALBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.07% yearly.

EPS 1Y (TTM)-122.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%178.98%

Revenue 1Y (TTM)-4.87%

Revenue growth 3Y-0.64%

Revenue growth 5Y0.07%

Sales Q2Q%7.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

ALBI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALBI is cheaper than 61.54% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.42

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALBI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GASCOGNE

EPA:ALBI (11/7/2025, 7:00:00 PM)

2.56

-0.02 (-0.78%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryContainers & Packaging

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners1.62%

Ins Owner ChangeN/A

Market Cap96.46M

Revenue(TTM)391.21M

Net Income(TTM)-625.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.25
P/FCF	N/A
P/OCF	4.41
P/B	0.45
P/tB	0.48
EV/EBITDA	7.42

EPS(TTM)-0.07

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-1.13

FCFYN/A

OCF(TTM)0.58

OCFY22.68%

SpS10.38

BVpS5.69

TBVpS5.36

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.1%
ROE	-0.29%
ROCE	1.29%
ROIC	0.88%
ROICexc	1.11%
ROICexgc	1.15%
OM	1.55%
PM (TTM)	N/A
GM	25.55%
FCFM	N/A

ROA(3y)2.18%

ROA(5y)2.37%

ROE(3y)5.63%

ROE(5y)6.16%

ROIC(3y)4.1%

ROIC(5y)4.24%

ROICexc(3y)4.63%

ROICexc(5y)4.82%

ROICexgc(3y)4.81%

ROICexgc(5y)5.01%

ROCE(3y)6.32%

ROCE(5y)6.56%

ROICexgc growth 3Y-40.81%

ROICexgc growth 5Y-24.33%

ROICexc growth 3Y-40.44%

ROICexc growth 5Y-24.35%

OM growth 3Y-27.15%

OM growth 5Y-15.85%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.32%

GM growth 5Y-1.26%

F-Score3

Asset Turnover0.6

Health

		Industry Rank	Sector Rank
Debt/Equity	1.19
Debt/FCF	N/A
Debt/EBITDA	8.29
Cap/Depr	260.52%
Cap/Sales	16.52%
Interest Coverage	1.29
Cash Conversion	70.88%
Profit Quality	N/A
Current Ratio	1.79
Quick Ratio	1.07
Altman-Z	1.3

F-Score3

WACC3.54%

ROIC/WACC0.25

Cap/Depr(3y)285.57%

Cap/Depr(5y)222.94%

Cap/Sales(3y)15.49%

Cap/Sales(5y)11.44%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-122.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%178.98%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-4.87%

Revenue growth 3Y-0.64%

Revenue growth 5Y0.07%

Sales Q2Q%7.54%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-66.43%

EBIT growth 3Y-27.62%

EBIT growth 5Y-15.79%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y10.94%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-35.07%

OCF growth 3Y-14.16%

OCF growth 5Y0.18%

GASCOGNE / ALBI.PA FAQ

What is the fundamental rating for ALBI stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALBI.PA.

Can you provide the valuation status for GASCOGNE?

ChartMill assigns a valuation rating of 1 / 10 to GASCOGNE (ALBI.PA). This can be considered as Overvalued.

Can you provide the profitability details for GASCOGNE?

GASCOGNE (ALBI.PA) has a profitability rating of 2 / 10.

How financially healthy is GASCOGNE?

The financial health rating of GASCOGNE (ALBI.PA) is 2 / 10.

GASCOGNE (ALBI.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

GASCOGNE / ALBI.PA FAQ

What is the fundamental rating for ALBI stock?

Can you provide the valuation status for GASCOGNE?

Can you provide the profitability details for GASCOGNE?

How financially healthy is GASCOGNE?